Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.33 EUR | +2.10% | +14.67% | +47.90% |
04-17 | OSE: licensing agreement with AbbVie enters into force | CF |
04-17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.90% | 144M | |
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- OSE Stock
- News OSE Immunotherapeutics
- OSE Immunotherapeutics Enrolls First Patient in Phase 2 Study Of Non-Small Cell Lung Cancer Treatment